Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roberto Elosua is active.

Publication


Featured researches published by Roberto Elosua.


Journal of Epidemiology and Community Health | 2003

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas

Jaume Marrugat; Ralph B. D'Agostino; Lisa Sullivan; Roberto Elosua; Peter W.F. Wilson; Jose M. Ordovas; Pascual Solanas; Ferran Cordón; Rafel Ramos; Joan Sala; Rafel Masiá; W B Kannel

Aim: To determine whether the Framingham function accurately predicts the 10 year risk of coronary disease and to adapt this predictive method to the characteristics of a Spanish population. Method and Results: A Framingham function for predicting 10 year coronary deaths and non-fatal myocardial infarction was applied to the population of the province of Gerona, Spain, where the cumulated incidence rate of myocardial infarction has been determined since 1988 by a specific registry. The prevalence of cardiovascular risk factors in this region of Spain was established in 1995 by a cross sectional study on a representative sample of 1748 people. The number of cases estimated by the Framingham function for 10 year coronary deaths and non-fatal myocardial infarction was compared with that observed. The Framingham function estimated 2425 coronary heart disease cases in women and 1181 were observed. In men, 9919 were estimated and 3706 were observed. Recalibrating the Framingham equations to the event rate and the prevalence of the risk factors in Gerona led to estimates very close to the number of cases observed in Gerona men and women. Conclusions: The Framingham function estimates more than doubled the actual risk of coronary disease observed in north east Spain. After calibration, the Framingham function became an effective method of estimating the risk in this region with low coronary heart disease incidence.


Journal of Epidemiology and Community Health | 2001

Role of age and sex in short-term and long term mortality after a first Q wave myocardial infarction

Jaume Marrugat; Gil M; Rafel Masiá; Joan Sala; Roberto Elosua; Antó Jm

STUDY OBJECTIVE The objective of this study was to analyse whether the risk of death within 28 days and three years after a first Q wave myocardial infarction was higher in hospitalised women than in men. DESIGN Follow up study. PATIENTS AND SETTING All consecutive first Q wave myocardial infarction patients aged 25 to 74 years (447 women and 2322 men) admitted to a tertiary hospital in Gerona, Spain, from 1978 to 1997 were registered and followed up for three years. MAIN RESULTS Women were older, presented more comorbidity and developed more severe myocardial infarctions than men. A significant interaction was found between sex and age. Women aged 65–74 had higher early mortality risk than men of the same age (OR 1.62; 95% CI 1.01, 2.66) after adjusting for age, comorbidity and acute complications including heart failure. Women under 65 tended to be at lower risk of early mortality than men (0.45 (95% CI 0.19, 1.04). Three year mortality of 28 day survivors did not differ between sexes. CONCLUSIONS These data support the idea that the higher 28 day mortality in hospitalised women with a first Q wave myocardial infarction is mainly attributable to the large number of patients aged 65 to 74 years in whom the risk is higher than that in men. Women under 65 with myocardial infarction do not seem to be a special group of risk.


Obesity Research | 2003

Obesity Modulates the Association among APOE Genotype, Insulin, and Glucose in Men

Roberto Elosua; Serkalem Demissie; L. Adrienne Cupples; F. James B. Meigs; Peter W.F. Wilson; Ernst J. Schaefer; Dolores Corella; Jose M. Ordovas


Archive | 2016

Recursos hospitalarios y letalidad por infarto de miocardio.

Eva E. Álvarez-León; Roberto Elosua; Alberto Zamora; Elena Aldasoro; Hermelinda Vanaclocha; Antonio Segura; Miquel Fiol; José M. Arteagoitia; María José Tormo; Gema Vega; José I. Ayestarán; Iraida Hurtado-de-Saracho; Oscar Zurriaga; Javier Muñiz; Joan Sala; Jaume Marrugat


Archive | 2011

Genetic markers for cardiovascular disease risk assessment

Eduardo Salas; Jaume Marrugar; Roberto Elosua; Sergio Castillo; Joan Salgado; Jose M. Ordovas


International Journal of Cardiovascular Practice | 2017

Evaluation of a Clinical Decision Support System for Dyslipidemia Treatment (HTE-DLPR) by QoE questionnaire

Alberto Zamora; Carme Carrion; Marta Aymerich; Xavier Castells; Lidia Blanco; Anabel Martín-Urda; Guillen Paluzie; Dolors Capellá; Roberto Elosua


Archive | 2016

Grupo de Investigacion en Genetica y Epidemiologia Cardiovascular, Programa de Investigacion en Procesos Inflamatorios y Cardiovasculares, IMIM-Hospital del Mar, Barcelona, Espana

Jaume Marrugat; Joan Vila; Roberto Elosua


Archive | 2016

RISK MARKERS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Eduardo Salas; Sara Pich; Manuel Arias; Roberto Elosua; Sergio Castillo


Archive | 2014

METODOS DE DIAGNOSTICO DE LA ENFERMEDAD TROMBOEMBOLICA

José Manuel Soria; Miroslava Ogorelkova; Roberto Elosua; Eduardo Salas; Sergio Castillo; Joan Vila


Archive | 2012

Thromboemoblic disease markers

Eduardo Salas; José Manuel Soria; Miroslava Ogorelkova; Roberto Elosua; Joan Vila; Sergio Castillo

Collaboration


Dive into the Roberto Elosua's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

José Manuel Soria

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Dolores Corella

United States Department of Agriculture

View shared research outputs
Researchain Logo
Decentralizing Knowledge